Natalya F. MacWilliams is a member of the Clinical Trials Review Boards of Massachusetts General Hospital and of Brigham and Women’s Hospital, both in Boston, which boards review and approve all clinical trials conducted at those institutions. After a successful early career as an investment banker with J.P. Morgan on Wall Street and before that as a management consultant with PricewaterhouseCoopers, she decided to redirect her professional focus to two of her true passions: medical consumer advocacy, and transparency in medical clinical trials and public affairs in general with special focus on her native Russia.
Among her honors, while at J.P. Morgan her team of four was judged to be the second best in the nation among all financial institutions in terms of the quality and output of its investigating and analyzing U.S. pharmacies.
In recent years she has been involved in numerous medical initiatives including: assisting in the establishment of Brigham & Women’s Hospital’s surgical outreach to Rwanda; developing and producing a nationally released film regarding the crucial role of military medics in Iraq and Landsthul, Germany; advising regarding the development of international telemedicine capabilities at Partners Center for Connected Health in Boston; and assisting in the establishment of the world’s largest program to provide reading glasses for the impoverished in the developing world.
Ms. MacWilliams was born and raised in St. Petersburg, Russia. She was educated at St. Petersburg State University in St. Petersburg, Russia; at Marymount Manhattan College in New York City where she received a BA in Management; and at the University of North Carolina at Chapel Hill where she received her MBA in Finance from Kenan-Flagler Business School.